Exabis Library
Welcome to the e-CCO Library!
P136 Faecal calprotectin as therapeutic target in patients with Crohn’s disease treated with anti-TNF: a meta-analysis of individual data
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P136: Association between histological indices and ulcerative colitis activity measures among patients in the HICKORY (etrolizumab) open-label induction cohort
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P136: Management of patients with Inflammatory Bowel Disease and their outcome during the first wave of Covid-19 pandemics.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P136: Multidimensional assessment of visceral hypervigilance in patients with IBD
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P136: Risk of polyps and colorectal cancer in patients with microscopic colitis: case-control study with long-term follow-up
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P136: Serum IL-17 and IL-23 levels can distinguish between severe and non-severe inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P136: Sporadic adenomas in IBD patients over 50 years old and average risk population – Is there a difference?
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P136: Validation of ulcerative colitis endoscopic index of severity (UCEIS) in Korea
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P137 Is there an abuse in the histological diagnosis of Crohn’s disease? (retrospective study)
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P137: Clinical and pathological correlations between primary and secondary ileal strictures in Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P137: Lesions of Cytomegalovirus and Epstein Barr virus of the proximal gastrointestinal tract in patients with Inflammatory Bowel Disease after COVID-19.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P137: Preliminary validation of a multi-stage machine learning algorithm to assess histological inflammation in inflammatory bowel disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P137: Serum biomarkers of degradation and formation of type III, IV and V collagen are associated with disease activity in patients with Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P137: The oxido-reductases enzymes (TDO2 and SOD2) in colonic mucosa are markers associated with histological activity and clinical course in ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P137: The prevalence and severity of sexual dysfunction in male IBD patients: an observational single-center study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P137: Ulcerative colitis in the elderly – Different disease course?
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P138 Basal plasma cells in normal large bowel: what is normal?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P138: Does depression at IBD diagnosis impact on disease outcomes in Crohn's?
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P138: Isolated ileal blind loop inflammation after ileocolonic resection in Crohn’s disease: An often neglected diagnosis with an unfavourable prognosis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P138: Platelet-to-lymphocyte ratio index: a reliable tool for non-invasive assessment of endoscopic activity in small bowel Crohn’s Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM